Cargando…
Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy
Photodynamic therapy (PDT) has emerged as an attractive therapeutic approach which can elicit immunogenic cell death (ICD). However, current ICD inducers are still very limited as the representative ICD induces of photosensitizers can only evoke insufficient ICD to achieve unsatisfactory cancer immu...
Autores principales: | Song, Haiqin, Cai, Zhenghao, Li, Juyi, Xiao, Haihua, Qi, Ruogu, Zheng, Minhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287983/ https://www.ncbi.nlm.nih.gov/pubmed/35842642 http://dx.doi.org/10.1186/s12951-022-01531-5 |
Ejemplares similares
-
Mechanism and In Vivo Evaluation: Photodynamic Antibacterial Chemotherapy of Lysine-Porphyrin Conjugate
por: Xu, Zengping, et al.
Publicado: (2016) -
Two-Photon Photodynamic Therapy by Water-Soluble Self-Assembled Conjugated Porphyrins
por: Ogawa, Kazuya, et al.
Publicado: (2013) -
Mono- and tri-cationic porphyrin–monoclonal antibody conjugates: photodynamic activity and mechanism of action
por: Smith, Karen, et al.
Publicado: (2011) -
Rational design of iridium–porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents
por: Zhang, Liping, et al.
Publicado: (2021) -
Application of Porphyrins in Antibacterial Photodynamic Therapy
por: Amos-Tautua, Bamidele M., et al.
Publicado: (2019)